Related Experiment Video
Updated: Jun 18, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children
Maria Paulke-Korinek1, Pamela Rendi-Wagner, Michael Kundi
1Department of Specific Prophylaxis and Tropical Medicine, Center for Physiology, Pathophysiology and Immunology, Medical University Vienna, Vienna, Austria.
Insights
Austria
Area of Science:
- Pediatrics
- Infectious Diseases
- Vaccinology
Background:
- Rotavirus vaccination subsidized for all Austrian children since July 2007.
- Achieved 72% vaccination coverage, rising to 87% in 2008.
Purpose of the Study:
- To evaluate the impact of a universal rotavirus vaccination program on hospitalization rates in children.
- To assess the effectiveness of the rotavirus vaccine in Austria.
Main Methods:
- Sentinel network of 11 pediatric hospital wards in Austria.
- Collected data on children hospitalized with rotavirus gastroenteritis (2001-2008).
- Analyzed hospitalization rates by age group before and after vaccine introduction.
Main Results:
- Significant decrease in rotavirus gastroenteritis hospitalization rates in infants (up to 12 months) by 74% within 18 months post-vaccination.
- Hospitalization rates also decreased in children aged 12-24 months.
- Vaccine field effectiveness estimated between 61% and 98%.
Conclusions:
- Universal rotavirus mass vaccination significantly reduced hospitalizations in the target cohort.
- The program demonstrated substantial public health impact within 18 months.
- Rotavirus vaccination is effective in preventing severe gastroenteritis in children.
Background:
Since July 2007, rotavirus vaccinations have been subsidized in Austria for all children from the seventh week up to the sixth month of life. Vaccination coverage over the whole period was 72% with an increase to 87% in 2008.
Methods:
In a sentinel network including 11 pediatric hospital wards in Austria, data of children up to 15 years of age and hospitalized due to rotavirus gastroenteritis between January 2001 and December 2008 have been collected.
Results:
The hospitalization rates of children up to 12 months of age with rotavirus gastroenteritis were 2066 x 10(-5) between 2001 and 2006 and decreased to 631 x 10(-5) in 2008. For children between 12 and 24 months of age the hospitalization rate decreased from 1822 x 10(-5) (2001-2006) to 1456 x 10(-5) in 2008. In children aged 2 to less than 5 years, incidence rates were 436 x10(-5) (2001-2006) and 461 x 10(-5) in 2008. In older children, the hospitalization rates remained unchanged. In the target population for the RV-vaccine, a decrease of hospitalization rates due to rotavirus gastroenteritis of 74% was observed compared to the era before the introduction of the vaccine. The field effectiveness of the vaccine was estimated between 61% and 98%, depending on assumptions about the vaccination status.
Conclusions:
Within 18 months, the universal mass vaccination program against rotavirus led to a substantial decrease in the hospitalization rates of the target cohort of the immunization program in Austria.
Related Concept Videos
Poliomyelitis
Vaccinations
Bacterial Gastroenteritis
Respiratory Syncytial Virus Disease
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
